PANACEA BIOTEC LTD Financial Ratios
PANACEABIO · Healthcare · Current price ₹391.8
P/E ratio
-269.3x
P/B ratio
11.9x
ROE
-2.4%
ROCE
-2.0%
Debt / Equity
0.93
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -269.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 11.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -2.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -2.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.93 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with PANACEA BIOTEC LTD's latest numbers.
PANACEA BIOTEC LTD profitability
PANACEA BIOTEC LTD generates a return on equity of -2.4% and a return on capital employed of -2.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.93 and a P/E of -269.3x, PANACEA BIOTEC LTD is moderately leveraged. Our overall business-quality score for the company is 3.6 / 10.
Understand the ratios
More on PANACEA BIOTEC LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.